Workflow
RadNet(RDNT)
icon
Search documents
RDNT Stock Up Post New Tie-Up to Boost Ultrasound Workflows With AI
ZACKS· 2024-12-03 16:20
Company Overview - RadNet, Inc. announced a partnership between its subsidiary DeepHealth, Inc. and Siemens Healthineers to enhance ultrasound operations using AI-powered health informatics [1][2] - The collaboration aims to improve operational efficiency and patient experience by integrating DeepHealth's SmartSonography solution with Siemens Healthineers' ultrasound systems [2][7] Strategic Importance - This partnership is a significant step for RadNet to strengthen its position in the global ultrasound AI market, which is expected to grow substantially [3][8] - The collaboration addresses challenges in high-volume ultrasound care settings, such as workforce shortages and variability in image quality, by enabling remote oversight of image acquisition [6][7] Financial Performance - RadNet has a market capitalization of $6.13 billion and a projected earnings per share growth of 19.3%, surpassing the industry average of 14.2% [5] - Following the announcement, shares of RadNet gained nearly 1.3%, reflecting positive market sentiment [4] Industry Prospects - The global AI in ultrasound imaging market was valued at approximately $818.20 million in 2022 and is projected to reach $1,686.18 million by 2030, growing at a CAGR of 8.6% [8] - Advancements in AI technology and increasing medical imaging needs are expected to drive market growth, benefiting RadNet's Digital Health segment [8] Recent Developments - DeepHealth has also partnered with CARPL.ai to develop an AI control system for image interpretation, enhancing AI scalability and performance [9] - New AI-powered solutions were launched at RSNA 2024, further integrating advanced AI with imaging systems for improved workflows [10]
RDNT Stock Up Following the New Tie-Up to Leverage Radiology AI
ZACKS· 2024-12-02 17:31
Core Viewpoint - RadNet, Inc. has announced a partnership between its subsidiary DeepHealth, Inc. and CARPL.ai to develop an AI control system for image interpretation, aimed at enhancing AI scalability, performance monitoring, and safety in radiology [1][2][5]. Company Developments - DeepHealth currently monitors the performance of its SmartMammo AI solution for breast cancer detection and aims to expand this control system to other applications and customers through the collaboration with CARPL.ai [2][5]. - The partnership is expected to create a closed-loop AI feedback system that will continuously monitor AI model accuracy and performance metrics, thereby improving clinical outcomes and operational efficiency [6][7]. - Recent collaborations by DeepHealth include partnerships with Siemens Healthineers and GE HealthCare to enhance ultrasound operations and develop SmartTechnology solutions for imaging [11][13]. - DeepHealth has also received expanded FDA 510(k) clearance for its SmartMammo Dx software, which is now compatible with GE HealthCare's mammography systems [12]. Market Performance - Following the announcement of the partnership, RadNet's shares gained nearly 0.1% in pre-market trading, reflecting positive market sentiment [3]. - RadNet has a market capitalization of $6.11 billion and a projected earnings per share growth of 19.3%, surpassing the industry average of 14.2% [4]. - Over the past year, RadNet's shares have increased by 132.1%, significantly outperforming the industry and the S&P 500 [14]. Industry Prospects - The global radiology market was valued at $30 billion in 2023 and is projected to reach $48.54 billion by 2031, growing at a CAGR of 6.2%, driven by technological advancements and changing healthcare needs [9][10].
RadNet's Wholly-Owned Subsidiary, DeepHealth, Launches New AI-powered Informatics and SmartTechnology™ Innovations at #RSNA2024
GlobeNewswire News Room· 2024-12-02 11:00
Core Insights - DeepHealth has launched new AI-powered solutions at RSNA 2024, aimed at enhancing imaging-based diagnosis and operational efficiency in healthcare [2][4] - The company introduced SmartTechnology™, which integrates advanced AI with imaging systems to create more efficient, patient-centric workflows [2][10] - Strategic collaborations with industry leaders such as GE HealthCare, Siemens Healthineers, and Google have been established to innovate and scale these solutions [2][4] DeepHealth OS - DeepHealth OS is a cloud-native, AI-powered operating system that unifies data across clinical and operational workflows, enhancing efficiency and personalization for stakeholders [3][5] - The OS supports seamless interoperability with existing hardware and software, ensuring a cohesive workflow across various imaging tasks [6] Diagnostic Suite - The Diagnostic Suite is a modernized Picture Archiving and Communication System (PACS) that offers a unified diagnostic workspace with advanced image management capabilities [7][8] - It features a fast streaming viewer and integrates AI infrastructure for continuous optimization of clinical AI performance [8] TechLive - TechLive is a remote centralized command center that allows technologists to access imaging devices across multiple locations, facilitating real-time scanning and collaboration [9] - This solution aims to standardize protocols and improve operational oversight in complex imaging environments [9] SmartTechnology - SmartTechnology solutions, including SmartMammo™ and SmartSonography™, enhance workflows by integrating AI with imaging systems for improved diagnostic accuracy and efficiency [10][11] - SmartMammo™ can return lesion scoring within five minutes of scanning, enabling faster breast cancer screening [11] - SmartSonography™ aims to improve ultrasound diagnostics by providing real-time remote imaging support [12] Broader Portfolio Updates - DeepHealth is also showcasing updates to its broader enterprise imaging and population health portfolio, including advancements in AI solutions for breast, lung, prostate, and brain health [15][16] - The company currently supports over 800 clinical sites and more than 3,000 radiologists with its existing solutions [16]
RadNet, Inc. to Present at the BofA Securities 2024 Leveraged Finance Conference on December 3, 2024
GlobeNewswire News Room· 2024-12-02 11:00
Core Viewpoint - RadNet, Inc. is a leading provider of diagnostic imaging services in the United States and will present at the BofA Securities 2024 Leveraged Finance Conference on December 3, 2024 [1][2]. Company Overview - RadNet operates a network of 399 outpatient imaging centers across various states including Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas [2]. - The company is recognized as the national leader in freestanding, fixed-site diagnostic imaging services based on the number of locations and annual imaging revenue [2]. - RadNet employs over 10,000 individuals, including full-time and per diem employees and technologists [2]. Presentation Details - The presentation by Mark Stolper, Executive Vice President and Chief Financial Officer, is scheduled for December 3, 2024, at 8:10 a.m. Eastern Time (5:10 a.m. Pacific Time) [1][2]. - The event will take place at the Boca Raton Resort in Boca Raton, Florida [2]. - Webcasts of the presentation will be available simultaneously and archived on RadNet's website [2].
Siemens Healthineers and RadNet's Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™
GlobeNewswire News Room· 2024-12-01 17:00
Siemens Healthineers and DeepHealth have signed a letter of intent to create AI-powered SmartTechnology™ to improve patient experience and operational efficiency in ultrasound. The collaboration aims to facilitate remote operations, collaboration, and enhanced interpretation capabilities for increased diagnostic accuracy and consistency by combining Siemens Healthineers’ Acuson Sequoia with RadNet’s DeepHealth SmartSonography™.A live demonstration of the technology will be held Tuesday, December 3, 10:00 AM ...
RadNet's Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai's Platform to Develop a New AI Control System for Clinical AI Performance and Safety
GlobeNewswire News Room· 2024-12-01 12:00
DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation to ensure AI scalability, performance monitoring, and safety, with the aim to accelerate the adoption of AI. DeepHealth currently monitors the performance of DeepHealth’s SmartMammo™ AI-powered solution for breast cancer detection at RadNet. Through the collaboration, the two companies aim to expand, productize and scale this control system across more ap ...
CORRECTION: RadNet's DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
GlobeNewswire News Room· 2024-11-29 14:43
Core Insights - The FDA has granted expanded clearance for DeepHealth's SmartMammo Dx AI algorithm, allowing compatibility with GE HealthCare's Senographe Pristina mammography systems, enhancing breast cancer detection capabilities [1][2][4] - This collaboration aims to improve breast cancer screening programs by leveraging AI technology to enhance diagnostic accuracy and operational efficiency in radiology workflows [3][5] Company Overview - RadNet, Inc. is a leading provider of diagnostic imaging services in the U.S., operating 399 outpatient imaging centers across multiple states [7] - DeepHealth, a subsidiary of RadNet, focuses on AI-powered health informatics, aiming to improve clinical outcomes and operational efficiency in various health domains, including breast cancer [9] Technology and Impact - SmartMammo Dx has been previously cleared for use with HOLOGIC systems and has supported millions of exams, indicating its effectiveness in enhancing breast cancer detection [4] - The integration of SmartMammo with GE HealthCare's systems is expected to accelerate the adoption of AI-driven breast cancer screening, benefiting both RadNet and other healthcare providers [4][5]
RadNet's DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
GlobeNewswire News Room· 2024-11-29 11:00
SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer detection. The clearance enables RadNet’s DeepHealth and GE HealthCare collaboration to bring together the SmartMammo and Senographe Pristina solutions and transform breast cancer diagnosis. SOMERVILLE, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered health informatics, has received expa ...
RadNet Secures Commitments to Amend its Credit Facility, Resulting in 0.25% Reduction in Interest Rates
GlobeNewswire News Room· 2024-11-22 16:00
LOS ANGELES, Nov. 22, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT),  a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today announced that it has completed pricing and allocations for Amendment No. 1 to Credit and Guaranty Agreement (the “First Amendment”) which will reduce the interest rates payable under its Third Amended and Restated First Lien Credit and Guaranty Agreement (the “Credit Agreement”). RadNet has $872,812,500 of outstand ...
RadNet Stock Pops on Earnings, GE HealthCare Partnership
Schaeffers Investment Research· 2024-11-11 15:42
The radiology stock is eyeing its best day since March 2020Radnet Inc (NASDAQ:RDNT) stock is soaring, last seen up 24% to trade at $89.11 at last glance, after the company reported better-than-expected earnings and revenue for the third quarter. In addition, the radiology name announced a new partnership with GE HealthCare (GEHC).RDNT is today pacing for its seventh-straight daily gain and biggest single-day percentage pop since March 2020. Shares already sport a 161.2% year-to-date lead, and earlier hit a ...